Skip to main content

Press Releases

News & Events

Donations Fund Advanced Technology to Improve the Surgical Experience for Breast Cancer Patients

For Immediate Release:  October 21, 2019

Livermore, CA -- Breast cancer is the second most common type of cancer in women and roughly 1 in 8 women born in the United States today will get breast cancer at some point in their lives, according to the Office of Disease Prevention and Health Promotion. Donations to ValleyCare Charitable Foundation (VCCF) helped to fund the purchase the state-of-the-art SAVI SCOUT® Radar Localization system used during breast conservation surgeries. An alternative to wire localization, SCOUT® is being used by surgeons and radiologists at Stanford Health Care – ValleyCare to precisely locate and direct the removal of a tumor during a lumpectomy or surgical biopsy procedure.

“Watching loved ones go through breast cancer surgery, I know that the surgery can be physically and emotionally distressing for the patients,” said Shaké Sulikyan, Executive Director of ValleyCare Charitable Foundation. “The Stanford Health Care – ValleyCare team is always striving to finds ways to create a better experience – and better outcomes – for our patients. VCCF is glad to fund the addition of SCOUT® to deliver cutting-edge care at our local Hospital.”

SCOUT® uses non-radioactive, radar technology to provide real-time surgical guidance during breast surgery. “It offers a new, high accuracy, wire-free solution in localizing tumor and atypia for breast conservation strategies and surgical biopsies. The SCOUT® reflector is the size of a grain of sand and can be placed up to 30 days prior to surgery in an outpatient setting, allowing flexibility in accommodating our patients’ busy schedules,” said Dr. Xin Ye, Breast Imaging Radiologist, Stanford Health Care – ValleyCare, and Clinical Assistant Professor, Radiology, Stanford University. “It is a welcome addition to our focus on patient-centered care.”

During surgery, the SCOUT® guide accurately detects the location of the reflector—and the tumor. The ability to precisely locate and direct the removal of a tumor during a lumpectomy or surgical biopsy procedure enables surgeons to increase the probability of complete cancer removal and reduce the likelihood of needing follow-up surgeries—a huge advantage for early-stage breast cancer patients. In addition, the ability to strategically plan the incision may result in less tissue being removed during surgery, resulting in better cosmetic outcomes.

“We are thankful to donors and ValleyCare Charitable Foundation for funding this important addition to our breast cancer program,” said Dr. Rishi Sawhney, Medical Director & Chair, Stanford Health Care – ValleyCare Cancer program, and medical oncologist. “As research and technology advances, we’re committed to adopting the safest and most progressive treatment options for our breast cancer patients.”

ValleyCare Charitable Foundation (VCCF) is an independent, nonprofit 501(c)(3) charitable organization dedicated to the health and better of the Tri-Valley through our ongoing funding of our community Hospital, Stanford Health Care – ValleyCare (SHC – VC) and its innovative programs. Forward-thinking and community-driven, we help ensure that you and your loved ones have access to world-class medical care and lifesaving services and technology. To learn more about VCCF and the impact of donations at SHC – VC or to make a donation to support the world-class medical care and program at the Hospital, visit or call 925-373-4560.


Contact information:

Shaké Sulikyan, Executive Director

Phone: (925) 373-4560